My Genome Screen
PrivateLast Round
Accelerator
May 20, 2024
Total Funding Raised
$30,000
Company Overview
My Genome Screen operates in Healthcare & Life Sciences and is based in Delaware. Its latest recorded funding round was an Accelerator round in May 2024.
My Genome Screen is a decision/risk analysis company that operates a personalized health diagnostics service using AI and genomic data to provide diagnoses, health alerts, and lifestyle recommendations for genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Precision Medicine, Biotechnology
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
My Genome Screen Comparables
Compare My Genome Screen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Breakthrough Genomics | 82% | |
| enGenome | 81% | |
| Saphetor | 79% |
For institutional investors. Book with your work email.
My Genome Screen Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
My Genome Screen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sabancı ARF | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2024
$30K raised from Sabancı ARF
For institutional investors. Book with your work email.
My Genome Screen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about My Genome Screen's valuation, stock price, and market status.
Is My Genome Screen a public or private company?
My Genome Screen is a private company.
What is the current stock price of My Genome Screen?
My Genome Screen is a private company, so its shares have no public market price. Caplight tracks My Genome Screen's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is My Genome Screen worth (valuation)?
Valuation information for My Genome Screen is not publicly available.
Can I buy My Genome Screen stock?
My Genome Screen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was My Genome Screen's last funding round?
My Genome Screen's most recent funding round was Accelerator on May 20, 2024.
Who are the main investors in My Genome Screen?
Key investors in My Genome Screen include Sabancı ARF.
Will My Genome Screen IPO soon?
No public IPO plans have been announced for My Genome Screen.
How can I track My Genome Screen secondary market activity?
Caplight tracks bids, offers, and trades in My Genome Screen's shares on secondary markets.